Quick Answer
NeuroPace Inc reported Long Term Debt of $58.88 million for the year ending 2025.
- NeuroPace Inc showed a decrease of -1.1% in Long Term Debt from 2024 to 2025.
- This data is from NeuroPace Inc's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $49.56 million | Q2 2021: $49.35 million | Q3 2021: $49.58 million | Q1 2022: $50.12 million | Q2 2022: $51.02 million | Q3 2022: $51.95 million | Q1 2023: $53.86 million | Q2 2023: $54.85 million | Q3 2023: $55.89 million | Q1 2024: $58.04 million | Q2 2024: $59.02 million | Q3 2024: $59.27 million | Q1 2025: $59.79 million | Q2 2025: $58.62 million | Q3 2025: $58.75 million.
- Over the full 6 years of available data (2020 to 2025), NeuroPace Inc's Long Term Debt has grown by 15.9%.
- Historical annual values: Fiscal year 2025: $58.88 million | Fiscal year 2024: $59.53 million | Fiscal year 2023: $56.95 million | Fiscal year 2022: $52.91 million | Fiscal year 2021: $49.85 million | Fiscal year 2020: $50.82 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: